Latest News of ISPR
CRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short Sellers
By Yahoo! Finance |
3 days ago
The article discusses ARK stocks and Cathie Wood's investment approach, focusing on disruptive innovation. It highlights CRISPR Therapeutics AG (NASDAQ:CRSP) and its potential in the gene sequencing i...
Tax credits in Biden's landmark climate law disproportionately benefit well-off
By The Guardian |
3 weeks ago
The Inflation Reduction Act has favored wealthy families over working-class Americans in accessing renewable energy incentives, hindering the US transition to clean energy. Experts suggest making ince...
5 Most Valuable 'Error Coins' Ever Minted -- Check For These Misprints
By Yahoo! Finance |
4 weeks ago
The value of a coin is determined by market demand, with limited supply coins being highly sought after. Errors in coins can significantly increase their value, with some reaching six figures. Familia...
-
Air pollution in NYC subway disproportionately impacts lower-income commuters, study says
By CBS News | 1 month agoA recent NYU study reveals that subway air pollution disproportionately affects low-income NYC commuters. The longer the commute, the higher the exposure to harmful pollutants, particularly impacting ...
-
Domesticating The Ground Cherry Using CRISPR Gene Editing
By Forbes | 1 month agoGoldenberries, also known as Physalis, are being studied by scientists to rapidly domesticate them into a resilient crop. These fruits have a unique taste and are easy to grow, but face challenges in ...
-
CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 1 month agoCRISPR Therapeutics AG is a gene editing company using CRISPR/Cas9 technology to develop gene-based medicines for various diseases. Their lead product, CASGEVY, aims to treat genetic blood disorders b...
-
CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History
By Yahoo! Finance | 1 month agoCRISPR Therapeutics AG is a gene editing company developing gene-based medicines for various diseases using its CRISPR/Cas9 platform. Their lead product candidate, CASGEVY, focuses on treating hemoglo...
-
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
By Yahoo! Finance | 1 month agoVertex Pharmaceuticals is a leading biotech company, specializing in cystic fibrosis treatments. It has diversified its portfolio with gene-editing therapies and pain treatments. CRISPR Therapeutics, ...
-
'Jeopardy!' fans outraged over mispronounced answer -- that Ken...
By New York Post | 2 months agoControversy arose on "Jeopardy!" when a contestant mispronounced "larynx" as "larnyx" but it was accepted as a correct answer. Fans expressed outrage, debating the pronunciation and recalling previous...
-
Ispire Technology Inc. (NASDAQ:ISPR) insiders have significant skin in the game with 66% ownership
By Yahoo! Finance | 2 months agoOwnership data reveals insiders hold 66% of Ispire Technology's shares, with CEO Tuanfang Liu as the largest shareholder. Institutional investors also have a stake, indicating positive analyst sentime...
-
Is CRISPR Therapeutics AG (CRSP) the Best Stock to Buy and Hold for 5 Years?
By Yahoo! Finance | 2 months agoInsider Monkey analyzed Cathie Wood's top stock picks for long-term investment. CRISPR Therapeutics AG (NASDAQ:CRSP) is highlighted as a revolutionary player in genetic sequencing. The company's poten...
-
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
By Yahoo! Finance | 2 months agoCRISPR Therapeutics shows promise in gene therapy with its groundbreaking treatments for genetic diseases. Despite challenges like establishing treatment centers and gaining long-term data, the compan...